PLIN5 Antikörper (AA 300-400)

Produktnummer ABIN363617

Produktdetails anti-PLIN5 Antikörper

Target: PLIN5 (Perilipin 5 (PLIN5))

Bindungsspezifität: AA 300-400

Reaktivität: Human, Maus, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLIN5 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC)

Spezifität: Reacts with OXPAT from human, mouse and bovine

Kreuzreaktivität (Details): Porcine (94 % ), Sheep (94 %).

Aufreinigung: Antigen affinity purified

Immunogen: Synthetic peptide made to a region of the human OXPAT protein within residues 300-400

Anwendungsinformationen

Applikationshinweise:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
IHC(1.0 - 5.0 μg/mL) WB(0.5 - 2.0 μg/mL)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1.01 mg/mL

Buffer: PBS, glycerol 30 % , Sodium azide 0.1 %

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.

Haltbarkeit: 6 months

Details zu PLIN5

Target: PLIN5 (Perilipin 5 (PLIN5))

Andere Bezeichnung: OXPAT (PLIN5 Produkte)

Synonyme: LSDA5 antikoerper, LSDP5 antikoerper, MLDP antikoerper, OXPAT antikoerper, 2310076L09Rik antikoerper, AI415325 antikoerper, AW109675 antikoerper, Lsdp5 antikoerper, PAT-1 antikoerper, perilipin 5 antikoerper, PLIN5 antikoerper, Plin5 antikoerper

Hintergrund: OXPAT is a novel PAT-1 protein that is expressed in highly oxidative tissues.Lipid droplet proteins of the PAT family regulate cellular neutral lipid stores.OXPAT is induced by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator-activated receptor [PPAR] agonists), and genetic (muscle-specific PPAR alpha overexpression) disturbances that increase fatty acid utilization.It is suggested that OXPAT is a marker for PPAR activation and fatty acid oxidation.As well, it may contribute to adaptive responses to the fatty acid responsibility that accompanies fasting, insulin deficiency, and overnutrition, responses that are defective in obesity and type 2 diabetes.